Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

The Original Article was published on 24 January 2018

Correction to: Eur J Hum Genet. 26:314–23; https://doi.org/10.1038/s41431-017-0081-3; published online 24 January 2018

Since the publication of the article, it has been noted that there is an error in Table 2. Where 550€ is listed in the final column of the table, this should have been written as 555€.

Table 2 Overall cost per patient (in Euro) of the NGS applications for targeted genes panel in eight germline oncogenetics laboratories

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Patricia Marino.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Marino, P., Touzani, R., Perrier, L. et al. Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study. Eur J Hum Genet 26, 1396–1397 (2018). https://doi.org/10.1038/s41431-018-0194-3

Download citation

Further reading

Search